A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection Csaba FehérAlex SorianoJosep Mensa Review Open access 01 December 2016 Pages: 1 - 35
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease Paul A. ChecchiaBosco PaesXavier Carbonell-Estrany Review Open access 09 January 2017 Pages: 37 - 56
Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application Juwon YimLeah M. MolloyJason G. Newland Review Open access 30 December 2016 Pages: 57 - 67
Infections in Cancer Patients with Solid Tumors: A Review Kenneth V. I. Rolston Review Open access 03 February 2017 Pages: 69 - 83
The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection Alaa Badawi Review Open access 29 November 2016 Pages: 85 - 102
Clinical Impact of an Antibiotic Stewardship Program at a Children’s Hospital Brian R. LeeJennifer L. GoldmanJason G. Newland Original Research Open access 02 December 2016 Pages: 103 - 113
Single-Dose Oritavancin Compared to Standard of Care IV Antibiotics for Acute Bacterial Skin and Skin Structure Infection in the Outpatient Setting: A Retrospective Real-World Study Patrick J. AnastasioPete WolthoffWeihong Fan Original Research Open access 11 January 2017 Pages: 115 - 128
In vitro Activity of Ceftolozane/Tazobactam Alone or with an Aminoglycoside Against Multi-Drug-Resistant Pseudomonas aeruginosa from Pediatric Cystic Fibrosis Patients Aimee M. DassnerChristina SutherlandDavid P. Nicolau Brief Report Open access 09 December 2016 Pages: 129 - 136
PK/PD Target Attainment With Ceftolozane/Tazobactam Using Monte Carlo Simulation in Patients With Various Degrees of Renal Function, Including Augmented Renal Clearance and End-Stage Renal Disease Alan J. XiaoLuzelena CaroRavina Kullar Brief Report Open access 24 December 2016 Pages: 137 - 148
